Cosmo Pharmaceuticals Statistics
Total Valuation
SWX:COPN has a market cap or net worth of CHF 1.05 billion. The enterprise value is 933.85 million.
Market Cap | 1.05B |
Enterprise Value | 933.85M |
Important Dates
The next estimated earnings date is Thursday, March 6, 2025.
Earnings Date | Mar 6, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SWX:COPN has 16.05 million shares outstanding. The number of shares has decreased by -0.77% in one year.
Current Share Class | n/a |
Shares Outstanding | 16.05M |
Shares Change (YoY) | -0.77% |
Shares Change (QoQ) | +0.54% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 15.71% |
Float | 8.42M |
Valuation Ratios
The trailing PE ratio is 15.80 and the forward PE ratio is 9.31.
PE Ratio | 15.80 |
Forward PE | 9.31 |
PS Ratio | 5.92 |
PB Ratio | 2.20 |
P/TBV Ratio | 10.95 |
P/FCF Ratio | 9.61 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.64, with an EV/FCF ratio of 8.51.
EV / Earnings | 13.94 |
EV / Sales | 5.23 |
EV / EBITDA | 9.64 |
EV / EBIT | 11.28 |
EV / FCF | 8.51 |
Financial Position
The company has a current ratio of 4.85, with a Debt / Equity ratio of 0.00.
Current Ratio | 4.85 |
Quick Ratio | 4.35 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.01 |
Debt / FCF | 0.01 |
Interest Coverage | 21.40 |
Financial Efficiency
Return on equity (ROE) is 14.80% and return on invested capital (ROIC) is 9.59%.
Return on Equity (ROE) | 14.80% |
Return on Assets (ROA) | 7.82% |
Return on Invested Capital (ROIC) | 9.59% |
Return on Capital Employed (ROCE) | 14.32% |
Revenue Per Employee | 526,444 |
Profits Per Employee | 197,600 |
Employee Count | 325 |
Asset Turnover | 0.27 |
Inventory Turnover | 3.19 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.04% in the last 52 weeks. The beta is 1.30, so SWX:COPN's price volatility has been higher than the market average.
Beta (5Y) | 1.30 |
52-Week Price Change | -1.04% |
50-Day Moving Average | 64.28 |
200-Day Moving Average | 69.79 |
Relative Strength Index (RSI) | 55.85 |
Average Volume (20 Days) | 18,743 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:COPN had revenue of CHF 178.46 million and earned 66.99 million in profits. Earnings per share was 4.16.
Revenue | 178.46M |
Gross Profit | 136.47M |
Operating Income | 82.78M |
Pretax Income | 83.39M |
Net Income | 66.99M |
EBITDA | 96.20M |
EBIT | 82.78M |
Earnings Per Share (EPS) | 4.16 |
Balance Sheet
The company has 128.45 million in cash and 1.40 million in debt, giving a net cash position of 127.05 million or 7.92 per share.
Cash & Cash Equivalents | 128.45M |
Total Debt | 1.40M |
Net Cash | 127.05M |
Net Cash Per Share | 7.92 |
Equity (Book Value) | 486.60M |
Book Value Per Share | 29.91 |
Working Capital | 140.30M |
Cash Flow
In the last 12 months, operating cash flow was 112.96 million and capital expenditures -3.21 million, giving a free cash flow of 109.75 million.
Operating Cash Flow | 112.96M |
Capital Expenditures | -3.21M |
Free Cash Flow | 109.75M |
FCF Per Share | 6.84 |
Margins
Gross margin is 76.47%, with operating and profit margins of 46.38% and 37.53%.
Gross Margin | 76.47% |
Operating Margin | 46.38% |
Pretax Margin | 46.72% |
Profit Margin | 37.53% |
EBITDA Margin | 53.90% |
EBIT Margin | 46.38% |
FCF Margin | 61.50% |
Dividends & Yields
This stock pays an annual dividend of 1.88, which amounts to a dividend yield of 2.86%.
Dividend Per Share | 1.88 |
Dividend Yield | 2.86% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | 6.07% |
Buyback Yield | 0.77% |
Shareholder Yield | 3.63% |
Earnings Yield | 6.35% |
FCF Yield | 10.41% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SWX:COPN has an Altman Z-Score of 5.97.
Altman Z-Score | 5.97 |
Piotroski F-Score | n/a |